|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4196 | |
| C07D 249/08 | |||
| A61P 31/18 |
| (11) | Patento numeris | 1789039 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05790722.2 |
| Europos patento paraiškos padavimo data | 2005-08-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-05-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-01-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/030259 |
| Data | 2005-08-25 |
| (87) | Numeris | WO 2006/026356 |
| Data | 2006-03-09 |
| (30) | Numeris | Data | Šalis |
| 604219 P | 2004-08-25 | US | |
| 604220 P | 2004-08-25 | US | |
| 686351 P | 2005-05-31 | US |
| (72) |
GIRARDET, Jean-Luc, US
KOH, Yung-Hyo, US
DE LA ROSA, Martha, US
GUNIC, Esmir, US
HONG, Zhi, US
LANG, Stanley, Valeant Research & Development, US
KIM, Hong, Woo, US
|
| (73) |
Ardea Biosciences, Inc.,
4939 Directors Place, San Diego, CA 92121,
US
|
| (54) | S-TRIAZOLYL ALPHA -MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE |
| S-TRIAZOLYL ALPHA -MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE |